Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
84 participants
INTERVENTIONAL
2023-03-18
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Two Different Kinds of Exercise on Stroke Rehabilitation
NCT00108680
Video-based Training for Rehabilitation of Upper Limb Functions After Stroke
NCT01242956
Effect of Mirror Therapy and Task Oriented Training for Persons With Paretic Upper Extremity
NCT02917343
Effect of Rhythmic Upper-limb Training in Stroke Patients
NCT02139553
Motor and Cognitive Functions in Acquired and Developmental Brain Damaged Patients
NCT02543424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 receiving physiotherapy only
Stroke patients will receive physiotherapy of upper limbs
Physiotherapy
Stroke patients will be randomly assigned to join one of the three groups. The first group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
Group 2 receiving combined physiotherapy and hypnosis
Stroke patients will receive physiotherapy of upper limbs under hypnosis
Physiotherapy and Hypnosis
Stroke patients will be randomly assigned to join one of the three groups. The second group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. Patients will continue their standard physiotherapy care during these 4 weeks. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
Waitlist group 3 receiving delayed combined physiotherapy and hypnosis
Stroke patients will receive physiotherapy of upper limbs under hypnosis one month after the other groups
Control group Physiotherapy and Hypnosis
The control group will be assessed initially and then after 4 weeks. After the second assessment, they will receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. All evaluation sessions will last approximately 1 hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapy
Stroke patients will be randomly assigned to join one of the three groups. The first group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
Physiotherapy and Hypnosis
Stroke patients will be randomly assigned to join one of the three groups. The second group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. Patients will continue their standard physiotherapy care during these 4 weeks. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
Control group Physiotherapy and Hypnosis
The control group will be assessed initially and then after 4 weeks. After the second assessment, they will receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. All evaluation sessions will last approximately 1 hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having experienced a stroke more than 3 months ago
* Understanding and proficient in the French language
* Having a functional capacity deficit in at least one of the two upper limbs
* Being able to independently travel to the Yerne medical center for necessary study appointments.
Exclusion Criteria
* Having a history of upper limb injuries (fractures, prosthetics, etc.)
* Having Wernicke's aphasia (language comprehension disorder)
* Having frontal lobe syndrome
* Undergoing chemotherapy
* Having respiratory disorders (respiratory failure of more than 70%) or receiving oxygen therapy
* Having epilepsy
* Having dementia
* Having untreated hearing impairments
* Being diagnosed with schizophrenia or paranoïa
* Experiencing significant concentration difficulties
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Audrey Vanhaudenhuyse
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Audrey Vanhaudenhuyse, PhD
Role: STUDY_DIRECTOR
University of Liege
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GIGA Science and Perception Research Group CHU Liège
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.